PHARMACOKINETIC, TOLERABILITY AND SAFETY PROFILE OF SA001 TABLET, A NOVEL ORAL TREATMENT FOR DRY EYE SYNDROME, AFTER SINGLE ADMINISTRATIONS IN HEALTHY SUBJECTS.

Kim Y.; Oh J.; Kim A.; Kim E.; Yoo H.; Yoon S.; Lee S.; Yu K. -S.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >PHARMACOKINETIC, TOLERABILITY AND SAFETY PROFILE OF SA001 TABLET, A NOVEL ORAL TREATMENT FOR DRY EYE SYNDROME, AFTER SINGLE ADMINISTRATIONS IN HEALTHY SUBJECTS.

【24h】

PHARMACOKINETIC, TOLERABILITY AND SAFETY PROFILE OF SA001 TABLET, A NOVEL ORAL TREATMENT FOR DRY EYE SYNDROME, AFTER SINGLE ADMINISTRATIONS IN HEALTHY SUBJECTS.

机译：SA001平板电脑的药代动力学，耐受性和安全性，一种干眼症综合征的新型口服治疗，在健康受试者中单一施用后。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2018年第1期|共1页
作者
Kim Y.; Oh J.; Kim A.; Kim E.; Yoo H.; Yoon S.; Lee S.; Yu K. -S.;
展开▼
作者单位

Seoul Natl Univ Coll Med &

Hosp Dept Clin Pharmacol &

Therapeut Seoul South Korea;

Seoul Natl Univ Coll Med &

Hosp Dept Clin Pharmacol &

Therapeut Seoul South Korea;

Ajou Univ Clin Trial Ctr Med Ctr Suwon South Korea;

Seoul Natl Univ Coll Med &

Hosp Dept Clin Pharmacol &

Therapeut Seoul South Korea;

Seoul Natl Univ Coll Med &

Hosp Dept Clin Pharmacol &

Therapeut Seoul South Korea;

Seoul Natl Univ Bundang Hosp Clin Trials Ctr Seongnam South Korea;

Seoul Natl Univ Coll Med &

Hosp Dept Clin Pharmacol &

Therapeut Seoul South Korea;

Seoul Natl Univ Coll Med &

Hosp Dept Clin Pharmacol &

Therapeut Seoul South Korea;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. PHARMACOKINETIC, TOLERABILITY AND SAFETY PROFILE OF SA001 TABLET, A NOVEL ORAL TREATMENT FOR DRY EYE SYNDROME, AFTER SINGLE ADMINISTRATIONS IN HEALTHY SUBJECTS. [J] . Kim Y., Oh J., Kim A., Clinical Pharmacology and Therapeutics . 2018,第Suppla1期

机译：SA001平板电脑的药代动力学，耐受性和安全性，一种干眼症综合征的新型口服治疗，在健康受试者中单一施用后。
2. PHARMACOKINETIC, TOLERABILITY AND SAFETY PROFILES OF SA001 TABLET, A NOVEL ORAL TREATMENT FOR DRY EYE SYNDROME, AFTER MULTIPLE ADMINISTRATIONS IN HEALTHY SUBJECTS. [J] . Kim Y., Oh J., Kim A., Clinical Pharmacology and Therapeutics . 2018,第Suppla1期

机译：SA001平板电脑的药代动力学，耐受性和安全谱，干眼症的新型口服治疗，在健康受试者的多个施用后。
3. PHARMACOKINETIC, TOLERABILITY AND SAFETY PROFILES OF SA001 TABLET, A NOVEL ORAL TREATMENT FOR DRY EYE SYNDROME, AFTER MULTIPLE ADMINISTRATIONS IN HEALTHY SUBJECTS. [J] . Kim Y., Oh J., Kim A., Clinical Pharmacology and Therapeutics . 2018,第Suppla1期

机译：SA001平板电脑的药代动力学，耐受性和安全谱，干眼症的新型口服治疗，在健康受试者的多个施用后。
4. Safety, tolerability, pharmacodynamics and pharmacokinetics following single subcutaneous dosesof a teverelix depot formulation in healthy male volunteers [C] . C. MacLean, F. Larsen, R. Piechatzek, Annual meeting exposition of the Controlled Release Society . 2005

机译：在健康男性志愿者中单次皮下注射Teverelix储库制剂后的安全性，耐受性，药效动力学和药代动力学
5. Pharmacokinetics, tissue depletion, target animal safety and live animal swab test accuracy after administration of long-acting oxytetracycline at double the label dose in healthy calves. [D] . TerHune, Terry Norman. 1988

机译：在健康小牛中，以双倍剂量服用长效土霉素后，药代动力学，组织耗竭，目标动物安全性和活体拭子测试准确性。
6. Safety Tolerability and Pharmacokinetics of a Novel Oral Amphotericin B Formulation (iCo-019) following Single-Dose Administration to Healthy Human Subjects: an Alternative Approach to Parenteral Amphotericin B Administration [O] . Peter Hnik, Ellen K. Wasan, Kishor M. Wasan 2020

机译：单剂量给予健康人对象后一种新型口服两性霉素B配方（ICO-019）的安全性耐受性和药代动力学：肠胃外两性霉素B给药的另一种方法
7. Pharmacokinetics, safety and tolerability of L-3-n-butylphthalide tablet after single and multiple oral administrations in healthy Chinese volunteers [O] . Meng Wang, Quan-ying Zhang, Wen-yan Hua, 2015

机译：L-3-正丁基苯酞片剂在健康中国志愿者单次和多次口服给药后的药代动力学，安全性和耐受性

PHARMACOKINETIC, TOLERABILITY AND SAFETY PROFILE OF SA001 TABLET, A NOVEL ORAL TREATMENT FOR DRY EYE SYNDROME, AFTER SINGLE ADMINISTRATIONS IN HEALTHY SUBJECTS.

著录项

相似文献

相关主题

期刊订阅